MS
77
-2
MCO
71
-7
CRM
60
-7
AME
74
-4
PEP
39
-9
FOX
51
-6
WMT
56
-4
HPE
44
-2
MSFT
48
-9
CINF
53
3
AMGN
42
-4
COF
62
3
FITB
60
-5
BMY
55
-8
SE
60
-3
CL
54
3
EXC
54
3
LEN
50
-2
HBI
58
3
STI
45
26
MS
77
-2
MCO
71
-7
CRM
60
-7
AME
74
-4
PEP
39
-9
FOX
51
-6
WMT
56
-4
HPE
44
-2
MSFT
48
-9
CINF
53
3
AMGN
42
-4
COF
62
3
FITB
60
-5
BMY
55
-8
SE
60
-3
CL
54
3
EXC
54
3
LEN
50
-2
HBI
58
3
STI
45
26
Financhill
Back

Mobile-health Network Solutions Vs. CytoMed Therapeutics Industry Stock Comparison

Sell
40

MNDR
Mobile-health Network Solutions

Last Price:
0.26
Seasonality Move:
--
Sell
50

GDTC
CytoMed Therapeutics

Last Price:
1.95
Seasonality Move:
-37.85%
Sell
40
Mobile-health Network Solutions (MNDR) is a Sell

Is Mobile-health Network Solutions a Buy, Sell or Hold?

  • The current Mobile-health Network Solutions [MNDR] share price is $0.26. The Score for MNDR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • MNDR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
CytoMed Therapeutics (GDTC) is a Sell

Is CytoMed Therapeutics a Buy, Sell or Hold?

  • The current CytoMed Therapeutics [GDTC] share price is $2.17. The Score for GDTC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • GDTC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MNDR Stock Price Chart

What is Mobile-health Network Solutions's stock price today?

  • The Mobile-health Network Solutions share price today is $0.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNDR is experiencing slight selling pressure.

GDTC Stock Price Chart

What is CytoMed Therapeutics's stock price today?

  • The CytoMed Therapeutics share price today is $2.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDTC is experiencing slight selling pressure.

MNDR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 24.15 Sell
Chaikin Money Flow: -282697 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.37 - 0.51) Sell
Bollinger Bands (100): (0.48 - 1.16) Sell

GDTC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 47.02 Sell
Chaikin Money Flow: -25 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.13 - 2.63) Sell
Bollinger Bands (100): (1.56 - 2.28) Buy

MNDR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.36 Sell
20-day SMA: 0.42 Sell
50-day SMA: 0.56 Sell
200-day SMA: 0 Buy
8-day EMA: 0.35 Sell
20-day EMA: 0.41 Sell
50-day EMA: 0.66 Sell
200-day EMA: 0.11 Buy

GDTC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.31 Sell
20-day SMA: 2.44 Sell
50-day SMA: 2.01 Buy
200-day SMA: 2.05 Buy
8-day EMA: 2.27 Sell
20-day EMA: 2.3 Sell
50-day EMA: 2.13 Buy
200-day EMA: 2.23 Sell

Mobile-health Network Solutions Earnings Growth & MNDR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.08 per share.

CytoMed Therapeutics Earnings Growth & GDTC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.02 per share.

Mobile-health Network Solutions Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CytoMed Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):